No definition available.
Benign neoplasm of colon, rectum, anus and anal canal
CD2_BENIGN_COLORECANI
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
25653 |
4. Check minimum number of eventsNone |
25653 |
5. Include endpoints |
26123 |
6. Filter based on genotype QC (FinnGen only) |
25190 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Similar endpoints
↥List of similar endpoints to Benign neoplasm of colon, rectum, anus and anal canal based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of colon, rectum, anus and anal canal
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 166694 | 83081 | 82674 |
Only index persons | 152318 | 77591 | 74727 |
Unadjusted period prevalence (%) | |||
Whole population | 2.34 | 2.38 | 2.31 |
Only index persons | 2.85 | 2.85 | 2.85 |
Median age at first event (years) | |||
Whole population | 66.20 | 66.21 | 66.18 |
Only index persons | 65.73 | 65.73 | 65.74 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 25190 | 12388 | 12802 |
Unadjusted period prevalence (%) | 5.66 | 4.87 | 6.43 |
Median age at first event (years) | 65.49 | 64.09 | 66.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_COLORECANI and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_COLORECANI | 1.236 [1.14, 1.34] | < 0.001 |
Birth year | 0.995 [0.99, 1.0] | 0.223 |
During the follow-up period (1.1.1998 — 31.12.2019), 14200 out of 66651 females with CD2_BENIGN_COLORECANI died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_COLORECANI | 1.328 [1.21, 1.45] | < 0.001 |
Birth year | 0.988 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 19311 out of 66453 males with CD2_BENIGN_COLORECANI died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_COLORECANI.N-year risk | Females | Males |
---|---|---|
1 | 0.104% | 0.227% |
5 | 0.658% | 1.578% |
10 | 1.776% | 3.844% |
15 | 3.638% | 7.17% |
20 | 6.368% | 12.114% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_COLORECANI – Benign neoplasm of colon, rectum, anus and anal canal
GWS hits: 19